๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA ยท Real-Time Price ยท USD
6.92
-0.06 (-0.86%)
Nov 20, 2026, 2:03 PM EST - Market open

Aura Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-145.23-112.79-96.12-84.99-60.3-35.25
Net Income
-136.95-106.19-86.92-76.41-58.76-46.19
Earnings Per Share
-1.61-1.76-1.75-1.93-1.96-8.95
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
297.23144.24151.09226.15188.81149.06
Total Debt
16.1717.3818.7719.5620.860.98
Net Cash (Debt)
281.06126.86132.33206.59167.95148.09
Net Cash Growth
95.03%-4.13%-35.95%23.01%13.41%751.42%
Net Cash Per Share
3.302.102.675.215.6128.70

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-109.3-84.74-79.81-63.85-54.6-32.41
Capital Expenditures
-0.38-0.45-1.25-0.71-1.09-2.13
Free Cash Flow
-109.68-85.19-81.06-64.56-55.7-34.54
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.